Palabras clave
Vapeadores
Biomarcadores
Cáncer de vejiga
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Investigar la relación entre el uso de vape y el riesgo de cáncer de vejiga, comparándolo con el tabaquismo tradicional y explorando los mecanismos biológicos subyacentes. Métodos: Revisión integrativa realizada en la base de datos PubMed Central (PMC), utilizando términos como "vaping," "vapers," "e-cigarettes," "carcinogens," "bladder cancer," y "carcinogenesis." Se seleccionaron 18 artículos para análisis. Resultados: Aunque el vape se promociona como una alternativa menos nociva que los cigarrillos tradicionales, no está exento de riesgos. Se encontraron niveles elevados de biomarcadores urinarios asociados con la carcinogénesis tanto en usuarios de vapes como en fumadores tradicionales. Las sustancias tóxicas del tabaco facilitan mutaciones e interrumpen la reparación del ADN, contribuyendo al desarrollo de cáncer de vejiga. Consideraciones finales: Se destaca la necesidad de campañas educativas para reducir el consumo de sustancias carcinógenas y políticas públicas que enfaticen los riesgos del vape. Los estudios sobre los impactos del vape están en fases iniciales, por lo que son esenciales investigaciones longitudinales para comprender mejor la relación entre el uso de cigarrillos electrónicos y el cáncer de vejiga.
Referencias
BESARATINIA A e TOMMASI S. An opportune and unique research to evaluate the public health impact of electronic cigarettes. Cancer Causes & Control, 2017; 28: 1167-1171.
BESARATINIA A e TOMMASI S. Electronic cigarettes: The road ahead. Preventive Medicine, 2014; 66: 101016.
BJURLIN MA, et al. Carcinogen Biomarkers in the Urine of Electronic Cigarette Users and Implications for the Development of Bladder Cancer: A Systematic Review. European Urology Oncology, 2021; 4: 766-783.
CABALLERO JM, et al. Environmental Factors Involved in the High Incidence of Bladder Cancer in an Industrialized Area in North-Eastern Spain. Journal of Environmental and Public Health, 2022; 1051046.
CANISTRO D, et al. E-cigarettes induce toxicological effects that can raise the cancer risk. Scientific Reports, 2017; 7(1): 2028.
COX S, et al. E-cigarette puffing patterns associated with high and low nicotine e-liquid strength: effects on toxicant and carcinogen exposure. BMC Public Health, 2016; 16: 1-9.
CUMBERBATCH MG, et al. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. European Urology, 2016; 70(3): 458-466.
FENG L, et al. Comparison of bladder carcinogenesis biomarkers in the urine of traditional cigarette users and e-cigarette users. Frontiers in Public Health, 2024; 12: 1385628.
GAUR S e AGNIHOTRI R. Health Effects of Trace Metals in Electronic Cigarette Aerosols—a Systematic Review. Biological Trace Element Research, 2018; 188: 295–315.
HAMAD SH, et al. Pilot study to detect genes involved in DNA damage and cancer in humans: potential biomarkers of exposure to e-cigarette aerosols. Genes, 2021; 12(3): 448.
IZQUIERDO-CONDOY JS, et al. Direct health implications of e-cigarette use: a systematic scoping review with evidence assessment. Frontiers in Public Health, 2024; 12: 1427752.
JIN F, et al. Tobacco-specific carcinogens induce hypermethylation, DNA adducts and DNA damage in Bladder Cancer. Cancer Prev Res (Phila). Author manuscript, 2017; 10(10): 588–597.
KANG JC e VALERIO JR LG. Investigating DNA adduct formation by flavor chemicals and tobacco byproducts in electronic nicotine delivery system (ENDS) using in silico approaches. Toxicology and Applied Pharmacology, 2020; 398: 115026.
LACOMBE L, et al. Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene–Smoking Interaction. Cancer Prevention Research, 2016; 9(2): 101158.
LEE HW, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proceedings of the National Academy of Sciences, 2018; 115(7): 1560-1569.
LEON ME, et al. European code against cancer: tobacco and cancer. Cancer Epidemiology, 2015; 39: 20-33.
LOHANI M, et al. Niacin deficiency modulates genes involved in cancer: Are smokers at higher risk? Journal of Cellular Biochemistry, 2018; 120(1): 232-242.
LORENZO-PARODI N, et al. Analysis of aromatic amines in human urine using comprehensive multi-dimensional gas chromatography-mass spectrometry (GCxGC-MS). International Journal of Hygiene and Environmental Health, 2024; 257: 114343.
MA B, et al. Recent studies on DNA adducts resulting from human exposure to tobacco smoke. Toxics, 2019; 7(1): 16.
MA W, et al. Can smoking cause differences in urine microbiome in male patients with bladder cancer? A retrospective study. Frontiers in Oncology, 2021; 11: 677605.
SAHU R, et al. E-cigarettes and associated health risks: an update on cancer potential. Advances in Respiratory Medicine, 2023; 91(6): 516-531.
TANG MS, et al. Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice. Proceedings of the National Academy of Sciences, 2019; 116(43): 21727-21731.
WOJTCZYK-MIASKOWSKA A e SCHLICHTHOLZ B. Tobacco carcinogens and the methionine metabolism in human bladder cancer. Mutation Research/Reviews in Mutation Research, 2019; 782: 108281.
ZULKIFLI A, et al. Electronic cigarettes: a systematic review of available studies on health risk assessment. Reviews on Environmental Health, 2018; 33(1): 43-52.